Register
Medicines reference
Product

Cortavance

Hydrocortisone aceponate · Virbac

1 form: topical (unspecified). In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Form Species Dose Frequency Georgia
0.584 mg/ml, Topical (unspecified) · Dog Dog 2 sprays
Two pump sprays per 10 x 10 cm of affected skin (1.52 micrograms/cm2), from about 10 cm, once a day: 7 days for inflammatory and pruritic dermatoses; at least 14 and up to 28 days for atopic dermatitis (recheck at day 14). The count is per area, not per dog. No more than about a third of the body surface.
· once daily: 7 days (dermatoses), 14-28 days (atopic dermatitis)
once daily: 7 days (dermatoses), 14-28 days (atopic dermatitis) Georgia Yes, veterinary
Details: pack, label wording, sources, registration

Cortavance 0.584 mg/ml, Topical (unspecified)

hydrocortisone aceponate 0.584 mg/ml, cutaneous spray, solution for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
8.4/10
Very good
vetman assessment

Cortavance

0.584 mg/ml, hydrocortisone aceponate 0.584 mg/ml, cutaneous spray, solution for dogs
Assessed clinical scopeDog · Local treatment of inflammatory and pruritic dermatoses and canine atopic dermatitis within the labelled surface-area and course limits · On the skin
Care settingVeterinary-directed outpatient dermatology care
vetman score 8.4/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · Verified on 18 Oct 2026

A strong local anti-inflammatory option for appropriately limited canine lesions, combining good evidence with lower systemic treatment burden.

Regulatory and scientific credibility8.5/10

The exact 0.584 mg/ml spray has a current 2026 UK SPC and active Georgian veterinary registration, with product-specific comparative evidence.

Clinical efficacy8.5/10

Hydrocortisone aceponate spray is guideline-supported for local canine atopic flares and has controlled evidence comparable with systemic ciclosporin in the studied setting.

Safety and tolerability8.0/10

Local delivery limits systemic exposure, but ulcers, hypersensitivity, young age, Cushing syndrome, reproduction and treatment of more than roughly one-third of body surface require caution.

Clinical practicality8.5/10

Two sprays per 10 x 10 cm once daily is precise and clinic-friendly for local disease; measuring surface area and reassessing longer atopic courses remain necessary.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not apply to cutaneous ulcers or in hypersensitivity to hydrocortisone aceponate.
  • Treat no more than about one-third of body surface; reassess at day 14 in longer atopic-dermatitis courses.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Hydrocortisone aceponate0.584 mg/ml
Formulation Type
Topical (unspecified)
Administration route
On the skin
Manufacturer
Virbac · France
Registration
Georgia Yes, veterinary
EU Yes, veterinary
№ EU/2/06/069
Verified on: 18 Oct 2026
UK Yes, veterinary
№ Vm 05653/5001
Verified on: 18 Oct 2026
US No
Verified on: 18 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 18 Oct 2026
DoseSpeciesWeightRouteFrequencySource
2 sprays
Two pump sprays per 10 x 10 cm of affected skin (1.52 micrograms/cm2), from about 10 cm, once a day: 7 days for inflammatory and pruritic dermatoses; at least 14 and up to 28 days for atopic dermatitis (recheck at day 14). The count is per area, not per dog. No more than about a third of the body surface.
Dog Any weight On the skin once daily: 7 days (dermatoses), 14-28 days (atopic dermatitis)
VMD SPC 2026
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Cortavance 0.584 mg/ml cutaneous spray solution for dogs - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2026

Known Contraindications

  • Critical
    Do not apply hydrocortisone aceponate to skin ulcers; in the ear, not with a perforated eardrum.
    Sources: UK SPC
  • Critical
    Do not use if hypersensitive to hydrocortisone aceponate or excipients.
    Sources: UK SPC
  • Caution
    Under 7 months: glucocorticoids slow growth; use after a benefit-risk assessment with regular checks.
    Sources: UK SPC
  • Caution
    Cushing syndrome: use only after a benefit-risk assessment. Treat no more than about a third of the body surface.
    Sources: UK SPC
  • Caution
    Pregnancy: use only after a benefit-risk assessment.
    Sources: UK SPC
  • Caution
    Lactation: use only after a benefit-risk assessment.
    Sources: UK SPC

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.